E
Eugene Braunwald
Researcher at Brigham and Women's Hospital
Publications - 1758
Citations - 278949
Eugene Braunwald is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 230, co-authored 1711 publications receiving 264576 citations. Previous affiliations of Eugene Braunwald include Boston University & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Determination of Fraction of Left Ventricular Volume Ejected per Beat and of Ventricular End-Diastolic and Residual Volumes Experimental and Clinical Observations with a Precordial Dilution Technic
Roland Folse,Eugene Braunwald +1 more
TL;DR: A technic has been developed that is sensitive to changes in left ventricular function and practical to apply routinely in the course of left heart catheterization and demonstrated in a circulatory model and in open-chest dogs.
Journal ArticleDOI
Left Heart Catheterization by the Transseptal Route A Description of the Technic and Its Applications
TL;DR: The advantages of transseptal left heart catheterization, which indicate its superiority over other technics, are discussed.
Journal ArticleDOI
A Randomized Trial to Evaluate the Relative Protection Against Post-Percutaneous Coronary Intervention Microvascular Dysfunction, Ischemia, and Inflammation Among Antiplatelet and Antithrombotic Agents: The PROTECT–TIMI-30 Trial
C. Michael Gibson,David A. Morrow,Sabina A. Murphy,Theresa M. Palabrica,Lisa K. Jennings,Peter Stone,Henry H. Lui,Thomas M Bulle,Nasser Lakkis,Richard Kovach,David J. Cohen,Polly Fish,Carolyn H. McCabe,Eugene Braunwald +13 more
TL;DR: Eptifibatide improved myocardial perfusion and reduced the duration of post-PCI ischemia but was associated with higher minor bleeding and transfusion rates; among moderate- to high-risk patients with ACS undergoing PCI, coronary flow reserve was greater with bivalirudin than eptifIBatide.
Journal ArticleDOI
Hyaluronidase-induced reductions in myocardial infarct size
TL;DR: The amount of myocardial necrosis that follows a coronary artery occlusion has been shown directly to be amenable to reduction with a pharmacological intervention.